MoMe ARC® Wireless Ambulatory ECG Monitoring and Detection System (32000)
Detector And Alarm, Arrhythmia. 510(k) K250356, from Infobionic, Inc. (Chelmsford, MA). Product code DSI, class 2.
As of Nov 18, 2026, K250356 is an FDA 510(k) held by Infobionic, Inc., substantially equivalent on Jul 29, 2025 after 172 days, with no recalls tied to it in FDA's recall database.
- Review time: 172 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFMoMe ARC® is indicated for: 1. Patients who experience transient symptoms that may suggest cardiac arrhythmia. 2. Patients who require monitoring of effect of drugs to control ventricular rate in various atrial arrhythmias (e.g. atrial fibrillation) 3. Patients with symptoms that may be due to cardiac arrhythmias.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- MoMe® ARC Wireless Ambulatory ECG Monitoring and Detection SystemK230265 · Infobionic, Inc. · Oct 6, 2023
Other DSI clearances
The newest 510(k)s for the same product code; their median review was 281 days; see every DSI device- BodyGuardian Remote Monitoring System (BGRMS v3.0)K243349 · Boston Scientific Cardiac Diagnostic Technologies, Inc. · Jan 23, 2026
- Zio AT® device (A100A1001)K240177 · iRhythm Technologies, Inc. · Oct 30, 2024
- MoMe® ARC Wireless Ambulatory ECG Monitoring and Detection SystemK230265 · Infobionic, Inc. · Oct 6, 2023
- SmartCardia 7L PlatformK231276 · Smartcardia SA · Aug 30, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 7, 2025
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1025
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files